160 related articles for article (PubMed ID: 27544663)
1. Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms.
Limberger KA; Bogatyreva L; Todorova R; Herde B; Hauschke D; Pahl HL; Werner M; Aumann K
Histochem Cell Biol; 2017 Jan; 147(1):75-82. PubMed ID: 27544663
[TBL] [Abstract][Full Text] [Related]
2. Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia.
Koopmans SM; Schouten HC; van Marion AM
Pathobiology; 2014; 81(2):60-8. PubMed ID: 24280934
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.
Medinger M; Skoda R; Gratwohl A; Theocharides A; Buser A; Heim D; Dirnhofer S; Tichelli A; Tzankov A
Br J Haematol; 2009 Jul; 146(2):150-7. PubMed ID: 19466975
[TBL] [Abstract][Full Text] [Related]
4. Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Pedersen MB; Riber-Hansen R; Nielsen PS; Bendix K; Hamilton-Dutoit SJ; D'Amore F; Steiniche T
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):577-84. PubMed ID: 24897068
[TBL] [Abstract][Full Text] [Related]
5. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
Medinger M; Tzankov A; Kern J; Pircher A; Hermann M; Ott HW; Gastl G; Untergasser G; Gunsilius E
Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
[TBL] [Abstract][Full Text] [Related]
6. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
7. Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms.
Schneider RK; Ziegler S; Leisten I; Ferreira MS; Schumacher A; Rath B; Fahrenkamp D; Müller-Newen G; Crysandt M; Wilop S; Jost E; Koschmieder S; Knüchel R; Brümmendorf TH; Ziegler P
J Hematol Oncol; 2014 Dec; 7():92. PubMed ID: 25498831
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Gianelli U; Iurlo A; Cattaneo D; Bossi A; Cortinovis I; Augello C; Moro A; Savi F; Castelli R; Brambilla C; Bianchi P; Primignani M; Cortelezzi A; Bosari S
Leuk Res; 2015 May; 39(5):525-9. PubMed ID: 25840747
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow pathology of myeloproliferative neoplasms].
Ito M
Rinsho Ketsueki; 2015 Aug; 56(8):956-62. PubMed ID: 26345553
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.
Lekovic D; Gotic M; Skoda R; Beleslin-Cokic B; Milic N; Mitrovic-Ajtic O; Nienhold R; Sefer D; Suboticki T; Buac M; Markovic D; Diklic M; Cokic VP
Ann Hematol; 2017 Mar; 96(3):393-404. PubMed ID: 27924369
[TBL] [Abstract][Full Text] [Related]
11. Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry.
Ng WY; Erber WN; Grigg A; Dunne K; Perkins A; Forsyth C; Ross DM
Pathology; 2024 Feb; 56(1):75-80. PubMed ID: 38071156
[TBL] [Abstract][Full Text] [Related]
12. Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
Muftah AA; Aleskandarany MA; Al-Kaabi MM; Sonbul SN; Diez-Rodriguez M; Nolan CC; Caldas C; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2017 Jul; 164(2):341-348. PubMed ID: 28478613
[TBL] [Abstract][Full Text] [Related]
13. [Our experience with detection of JAK2 mutations in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative disorders].
Burjanivová T; Marcinek J; Minárik G; Lasabová Z; Szépe P; Balhárek T; Vanochová A; Plank L
Cesk Patol; 2011 Jul; 47(3):115-7. PubMed ID: 21887928
[TBL] [Abstract][Full Text] [Related]
14. [The unclassifiable myeloproliferative neoplasm--morphological, cytogenetic and clinical features].
Borovecki A; Skrtić A; Paro MM; Lasan R; Dominis M
Acta Med Croatica; 2011 Sep; 65 Suppl 1():31-6. PubMed ID: 23126027
[TBL] [Abstract][Full Text] [Related]
15. β-catenin and PPAR-γ levels in bone marrow of myeloproliferative neoplasm: an immunohistochemical and ultrastructural study.
Subotički T; Mitrović Ajtić O; Mićić M; Kravić Stevović T; Đikić D; Diklić M; Leković D; Gotić M; Čokić VP
Ultrastruct Pathol; 2018; 42(6):498-507. PubMed ID: 30582392
[TBL] [Abstract][Full Text] [Related]
16. WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experience.
Madelung AB; Bondo H; Stamp I; Løvgreen P; Nielsen SL; Falensteen A; Knudsen H; Svendsen KD; Lange T; Ralfkiaer E; Nielsen K; Hasselbalch H; Thiele J
APMIS; 2015 Sep; 123(9):787-92. PubMed ID: 26200697
[TBL] [Abstract][Full Text] [Related]
17. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a bone marrow tissue microarray.
Zimpfer A; Schönberg S; Lugli A; Agostinelli C; Pileri SA; Went P; Dirnhofer S
J Clin Pathol; 2007 Jan; 60(1):57-61. PubMed ID: 16698953
[TBL] [Abstract][Full Text] [Related]
19. CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms.
Nomani L; Bodo J; Zhao X; Durkin L; Loghavi S; Hsi ED
Am J Clin Pathol; 2016 Oct; 146(4):431-8. PubMed ID: 27686170
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.
Koopmans SM; Bot FJ; Lam KH; van Marion AM; de Raeve H; Hebeda KM
Am J Clin Pathol; 2011 Oct; 136(4):618-24. PubMed ID: 21917685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
